Kalpana Luthra

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Hepatitis C Virus

Men Who Have Sex With Men

Top Venues

American journal of human biology : the official journal of the Human Biology Council

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Sanjeev Kumar, Swarandeep Singh, Kalpana Luthra
An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1. ACS omega 8 (8) (2023)
Sanjeev Kumar, Swarandeep Singh, Kalpana Luthra
An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1. ACS omega 8 (8) (2023)
Kiran Meena, Anoop Misra, Naval Kishore Vikram, Shakir Ali, Ashish Datt Upadhyay, Kalpana Luthra
Genetic polymorphism of fatty acid binding protein-2 in hyperlipidemic Asian Indians in North India. American journal of human biology : the official journal of the Human Biology Council (2022)
Nitesh Mishra, Sanjeev Kumar, Swarandeep Singh, Tanu Bansal, Nishkarsh Jain, Sumedha Saluja, Rajesh Kumar, Sankar Bhattacharyya, Jayanth Kumar P, Riyaz Ahmad Mir, Subrata Sinha, Kalpana Luthra
Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma. PLoS pathogens 17 (9) (2021)
Nitesh Mishra, Shaifali Sharma, Ayushman Dobhal, Sanjeev Kumar, Himanshi Chawla, Ravinder Singh, Bimal Kumar Das, Sushil Kumar Kabra, Rakesh Lodha, Kalpana Luthra
A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex. Journal of virology 94 (19) (2020)
Nitesh Mishra, Shaifali Sharma, Ayushman Dobhal, Sanjeev Kumar, Himanshi Chawla, Ravinder Singh, Muzamil Ashraf Makhdoomi, Bimal Kumar Das, Rakesh Lodha, Sushil Kumar Kabra, Kalpana Luthra
Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection. Nature communications 11 (1) (2020)